A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. (Q40456744)
Jump to navigation
Jump to search
scientific article published on January 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. |
scientific article published on January 2005 |
Statements
1 reference
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. (English)
1 reference
B I Eriksson
1 reference
O E Dahl
1 reference
H R Büller
1 reference
R Hettiarachchi
1 reference
N Rosencher
1 reference
M-L Bravo
1 reference
L Ahnfelt
1 reference
F Piovella
1 reference
J Stangier
1 reference
P Kälebo
1 reference
P Reilly
1 reference
BISTRO II Study Group
1 reference
1 January 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference